Trial
NCT00369629
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
National Cancer Institute (NCI); Eli Lilly and Company
Condition
Lymphoma
Intervention
Gemcitabine
Why stopped
This was planned as a phase I/II study originally, but due to a lack of funding, the phase II portion was never conducted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-28